| Recruitment status | Preinitiation |
| Unique ID issued by UMIN | UMIN000029166 |
| Receipt No. | R000033347 |
| Official scientific title of the study | Retrospective study of the diagnostic accuracy of CT scan in evaluation of resectability of Boderline resectable pancareatic cancer after neoadjuvant S-1 and concurrent radiotherapy |
| Date of disclosure of the study information | 2017/09/21 |
| Last modified on | 2017/09/20 (Ver. 8) |
| Basic information | ||
| Official scientific title of the study | Retrospective study of the diagnostic accuracy of CT scan in evaluation of resectability of Boderline resectable pancareatic cancer after neoadjuvant S-1 and concurrent radiotherapy
|
|
| Title of the study (Brief title) | JASPAC05 A-2 | |
| Region |
|
|
| Condition | |||
| Condition | Borderline resectable pancreatic cancer | ||
| Classification by specialty |
|
||
| Classification by malignancy | Malignancy | ||
| Genomic information | NO | ||
| Objectives | |
| Narrative objectives1 | To clarify the singnificance of enhanced CT scan in diagnosis of Boderline resectatable pancreatic cancer resectability. |
| Basic objectives2 | Efficacy |
| Basic objectives -Others | |
| Trial characteristics_1 | |
| Trial characteristics_2 | |
| Developmental phase | |
| Assessment | |
| Primary outcomes | The diagnostic accuracy of CT scan in evaluation of resectability of Boderline resectatable pancreatic cancer.
|
| Key secondary outcomes | Resection rate of converted Boderline resectatable pancreatic cancer (diagnosed by CT scan). |
| Base | |
| Study type | Observational |
| Study design | |
| Basic design | |
| Randomization | |
| Randomization unit | |
| Blinding | |
| Control | |
| Stratification | |
| Dynamic allocation | |
| Institution consideration | |
| Blocking | |
| Concealment | |
| Intervention | |
| No. of arms | |
| Purpose of intervention | |
| Type of intervention | |
| Interventions/Control_1 | |
| Interventions/Control_2 | |
| Interventions/Control_3 | |
| Interventions/Control_4 | |
| Interventions/Control_5 | |
| Interventions/Control_6 | |
| Interventions/Control_7 | |
| Interventions/Control_8 | |
| Interventions/Control_9 | |
| Interventions/Control_10 | |
| Eligibility | ||||
| Age-lower limit |
|
|||
| Age-upper limit |
|
|||
| Gender | Male and Female | |||
| Key inclusion criteria | 1) adenocarcinoma or adenosquamous carcinoma
2) no distant metastasis 3) borderline resectable pancreatic cancer 4) age 20-75 5) ECOG PS 0-1 6) No prior therapy 7) can be included in the irradiation field of 10cm x10cm 8) good oral intake 9) adequate biliary drainage for obstructive jaundice 10) no invasion to digestive tract 11) good main organ function 12) written informed consent |
|||
| Key exclusion criteria | 1) no prior fluoropyrimidine anticancer therapy
2) prior abdominal radiotherapy 3) diarrhea 4) iodine contrast allergy 5) pulmonary fibrosis or interstitial pneumonitis 6) ascites or pleural effusion 7) active infection 8) poor controlled diabetes 9) active other malignancy 10) active digestive ulcer 11) serious complications 12) continuous steroid administration 13) severe mental disorder 14) pregnancy |
|||
| Target sample size | 53 | |||
| Research contact person | |
| Name of lead principal investigator | Tatsushi Kobayashi |
| Organization | National Cancer Center Hospital East |
| Division name | Department of Radiology |
| Address | 6-5-1 Kashiwanoha, Kashiwa city, Chiba 277-8577, JAPAN |
| TEL | +81-471-33-1111 |
| takobaya@east.ncc.go.jp | |
| Public contact | |
| Name of contact person | Hidetoshi Aizawa |
| Organization | National Cancer Center Hospital East |
| Division name | Deparment of Hepatobiliary and Pancreatic Surgery |
| Address | 6-5-1 Kashiwanoha, Kashiwa city, Chiba 277-8577, JAPAN |
| TEL | +81-471-33-1111 |
| Homepage URL | |
| haizawa@east.ncc.go.jp | |
| Sponsor | |
| Institute | National Cancer Centor Japan |
| Institute | |
| Department | |
| Funding Source | |
| Organization | AMED |
| Organization | |
| Division | |
| Category of Funding Organization | Other |
| Nationality of Funding Organization | |
| Other related organizations | |
| Co-sponsor | |
| Name of secondary funder(s) | |
| Secondary IDs | |
| Secondary IDs | YES |
| Study ID_1 | JASPAC05 A-2 |
| Org. issuing International ID_1 | JASPAC |
| Study ID_2 | |
| Org. issuing International ID_2 | |
| IND to MHLW | |
| Institutions | |
| Institutions | |
| Other administrative information | |||||||
| Date of disclosure of the study information |
|
||||||
| Progress | |||||||
| Recruitment status | Preinitiation | ||||||
| Date of protocol fixation |
|
||||||
| Anticipated trial start date |
|
||||||
| Last follow-up date | |||||||
| Date of closure to data entry | |||||||
| Date trial data considered complete | |||||||
| Date analysis concluded | |||||||
| Related information | |
| URL releasing protocol | |
| Publication of results | Unpublished |
| URL releasing results | |
| Results | |
| Other related information | To be opened to public |
| Management information | |||||||
| Registered date |
|
||||||
| Last modified on |
|
||||||
| Link to view the page | |
| URL(English) | https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000033347 |